For instance, genetic ablation of IL1RL1 protected mice from developing experimental inflammatory bowel disease, and an antagonist of IL1RL1 could reduce the symptoms of colitis in these animals (Sedhom et al., 2013). The gene discussed is IL1RL1; the disease is inflammatory bowel disease.